Drdgold (DRDGF) Cash & Equivalents (2017 - 2025)

Drdgold's Cash & Equivalents history spans 9 years, with the latest figure at $71.5 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents rose 154.49% year-over-year to $71.5 million; the TTM value through Jun 2025 reached $71.5 million, up 154.49%, while the annual FY2025 figure was $72.2 million, 158.58% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $71.5 million at Drdgold, up from $28.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $163.0 million in Q2 2022 and bottomed at $28.1 million in Q2 2024.
  • The 5-year median for Cash & Equivalents is $132.9 million (2023), against an average of $109.9 million.
  • The largest annual shift saw Cash & Equivalents crashed 78.85% in 2024 before it soared 154.49% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $154.2 million in 2021, then grew by 5.71% to $163.0 million in 2022, then dropped by 18.47% to $132.9 million in 2023, then plummeted by 78.85% to $28.1 million in 2024, then skyrocketed by 154.49% to $71.5 million in 2025.
  • Per Business Quant, the three most recent readings for DRDGF's Cash & Equivalents are $71.5 million (Q2 2025), $28.1 million (Q2 2024), and $132.9 million (Q2 2023).